Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
On NRC, our newest investment, I discussed the company's evolution from owner / operator to professionally led management team, and the expected benefits from putting a growth focused, incentivized and entrepreneurial executive suite behind this strong and recognizable brand, in a business with strong FCF generation and in a market where the two leading competitors just merged in a PE backed $6.5B deal. Quantitative evidence that...
— Avram Fisher
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on National Research Corporation
More institutional theses from Long Cast Advisers
MTRX remains a top five holding despite the stock declining 30% in the quarter. I had expected...
RSSS, which has declined nearly 40% year to date, is no longer at top-five holding but remains a large position nonetheless. It is also...
With that in mind, and with earnings season in gear, Zimmer’s CEO recently shared positive commentary about the upcoming launch of its new robotic TKA platform on which PDEX, our largest holding, will be a major supplier: We recently announced a multi-year limited distribution and supply agreement with THINK Surgical to distribute an exclusive version of the only wireless handheld TMINI Miniature Robotic System compatible with Persona Knee. Most excitingly, we...